Supportive Care (for active infection)

Treatment for Yellow Fever

Typical Dosage: Varies (e.g., IV fluids, paracetamol, oxygen support)

Effectiveness
70%
Safety Score
85%
Clinical Trials
1,000
Participants
1M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
Varies (e.g., IV fluids, paracetamol, oxygen support)
Time to Effect
Immediate for symptom relief
Treatment Duration
1-2 weeks (duration of acute illness)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,000
Monitoring:$45,000
Side Effect Mgmt:$1,000
Total Annual:$48,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$3,333/QALY
QALYs Gained
15
Outcome-Based Costs
Cost per Responder
$80,000
Supportive Care (for active infection) Outcomes

for Yellow Fever

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+60%
Common Side Effects
Fluid overload
+1%
Electrolyte imbalance
+2%
Adverse drug reactions (e.g., from antipyretics, antibiotics)
+5%
Complications from organ support (e.g., dialysis, intubation)
+3%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov